DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)

DongKook Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	66,518	50,272	60,552	73,693	85,444	54,537
Short-Term Investments	34,822	40,582	33,608	29,512	83,439	120,425
Trading Asset Securities	14,796	-	-	3,899	1,047	1,329
Cash & Short-Term Investments	116,136	90,854	94,160	107,105	169,929	176,291
Cash Growth	31.11%	-3.51%	-12.09%	-36.97%	-3.61%	13.96%
Accounts Receivable	192,639	180,595	161,107	134,072	123,949	122,675
Other Receivables	22,219	22,000	17,779	17,361	14,046	12,745
Receivables	221,578	209,389	179,061	151,600	139,299	136,983
Inventory	163,854	159,577	138,343	120,152	102,591	79,048
Prepaid Expenses	4,043	4,639	4,058	2,629	3,949	1,723
Other Current Assets	5,743	5,547	3,575	3,836	4,457	4,717
Total Current Assets	511,354	470,007	419,197	385,321	420,226	398,763
Property, Plant & Equipment	295,419	299,459	272,705	263,355	234,941	194,967
Long-Term Investments	111,940	119,662	108,300	87,892	71,363	47,375
Goodwill	12,172	12,172	-	-	-	-
Other Intangible Assets	19,708	19,733	8,537	8,202	6,916	7,299
Long-Term Accounts Receivable	-0	-0	-	-	-	-
Long-Term Deferred Tax Assets	1,706	1,892	1,702	1,695	1,970	1,944
Long-Term Deferred Charges	10,670	10,594	7,626	2,672	-	-
Other Long-Term Assets	20,329	19,646	15,466	13,191	8,655	6,816
Total Assets	983,298	953,165	839,535	768,330	750,076	663,165
Accounts Payable	91,113	80,351	62,069	33,405	29,171	26,523
Accrued Expenses	4,635	4,212	3,624	2,754	3,603	2,087
Short-Term Debt	45,444	46,744	48,228	36,954	82,191	13,854
Current Portion of Long-Term Debt	2,227	2,227	5,729	-	-	-
Current Portion of Leases	2,718	3,089	2,528	1,954	2,044	2,557
Current Income Taxes Payable	12,439	14,085	4,949	10,293	6,758	11,891
Current Unearned Revenue	225.99	416.12	0.95	0.86	0.78	0.84
Other Current Liabilities	80,801	81,568	75,982	88,153	96,501	88,053
Total Current Liabilities	239,602	232,692	203,111	173,514	220,269	144,966
Long-Term Debt	22,805	22,904	18,750	25,000	10,000	49,000
Long-Term Leases	4,859	5,723	1,469	2,449	3,687	3,115
Long-Term Deferred Tax Liabilities	5,672	6,505	4,846	4,806	5,765	3,288
Other Long-Term Liabilities	5,318	6,364	7,144	6,471	6,378	6,607
Total Liabilities	279,514	274,189	235,319	212,241	246,099	207,431
Common Stock	22,442	22,230	22,230	22,230	22,230	22,230
Additional Paid-In Capital	23,898	24,800	16,944	14,371	14,459	14,293
Retained Earnings	565,490	558,208	507,318	467,179	419,761	376,729
Treasury Stock	-3,016	-3,016	-3,053	-3,095	-3,138	-3,138
Comprehensive Income & Other	869.51	869.51	869.51	869.51	869.51	869.51
Total Common Equity	609,684	603,092	544,309	501,554	454,181	410,983
Minority Interest	93,926	75,499	31,480	29,125	27,079	24,438
Shareholders' Equity	703,784	678,976	604,216	556,089	503,977	455,734
Total Liabilities & Equity	983,298	953,165	839,535	768,330	750,076	663,165
Total Debt	78,052	80,687	76,704	66,357	97,922	68,526
Net Cash (Debt)	38,084	10,167	17,456	40,748	72,008	107,765
Net Cash Growth	78.29%	-41.76%	-57.16%	-43.41%	-33.18%	14.14%
Net Cash Per Share	851.98	227.26	390.25	911.09	1610.23	2409.84
Filing Date Shares Outstanding	44.23	43.97	43.96	43.96	43.95	43.95
Total Common Shares Outstanding	44.23	43.97	43.96	43.96	43.95	43.95
Working Capital	271,752	237,315	216,087	211,807	199,957	253,796
Book Value Per Share	13785.80	13716.51	12381.26	11410.55	10334.43	9351.51
Tangible Book Value	577,805	571,187	535,772	493,352	447,265	403,684
Tangible Book Value Per Share	13064.97	12990.87	12187.07	11223.95	10177.07	9185.42
Land	114,630	114,638	102,959	107,234	91,415	82,086
Buildings	132,130	132,740	114,323	82,855	56,325	52,435
Machinery	243,197	239,876	211,538	172,505	158,211	138,956
Construction In Progress	9,311	9,257	7,535	46,091	57,785	36,871

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.